Pear Therapeutics- Warrants (01/12/2026) Operating Income

Pear Therapeutics- Warrants (01/12/2026) (PEARW) currently reports a operating income of $-120M as of December 2022. That compares with $-36M in the prior-year period — down 241.4% year over year. Use the charts on this page to explore Pear Therapeutics- Warrants (01/12/2026)'s operating income history and peer comparisons.

Pear Therapeutics- Warrants (01/12/2026)'s operating income decreased from $-36M to $-120M — a 241.4% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pear Therapeutics- Warrants (01/12/2026) reported $-120M in operating income as of December 2022. That compares with $-36M in the prior-year period — down 241.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pear Therapeutics- Warrants (01/12/2026), and consider following PEARW for alerts when major investors trade the stock.